[Adverse drug reactions of psychotropic agents: adverse drug reactions and safety monitoring of psychotropic agents]

Tomofumi Miura, Shoichiro Nakanishi, Shigenobu Kanba, Hiroyuki Uchida, Takeo Saio, Eiji Suzuki, Yutaro Suzuki, Keisuke Takahashi, Atsuo Nakagawa, Masahiko Mikuni, Kazuo Yamada

Research output: Contribution to journalReview article

Abstract

Pharmacological treatments of psychiatric illness have been developed and many psychotropic drugs are now on the market. The body of safety information regarding psychotropic agents is so large that it is difficult for clinicians to consider all the details of possible adverse drug reactions(ADRs) in daily clinical practice. Although it is impossible to predict and prevent all occurrences of ADRs, many of them may be preventable. In this context, there is a strong need for compact manuals of diagnosis and treatment for ADRs arising from psychotropic agents that are likely to be used in daily practice. Under the auspices of the Japanese Society of Psychiatry and Neurology, a task force was convened to answer this need. This review focuses on the general considerations of ADRs with psychotropic agents, based on discussions of the task force. We also discuss the guidelines for drug safety monitoring, targeted towards specific psychiatric disorders or patients taking specific classes of drugs. Finally, we introduce the Adverse Drug Reactions Relief System in Japan.

Original languageEnglish
Pages (from-to)735-745
Number of pages11
JournalSeishin shinkeigaku zasshi = Psychiatria et neurologia Japonica
Volume116
Issue number9
Publication statusPublished - 2014 Jan 1
Externally publishedYes

Fingerprint

Drug-Related Side Effects and Adverse Reactions
Safety
Psychiatry
Advisory Committees
Drug Monitoring
Psychotropic Drugs
Neurology
Japan
Pharmacology
Guidelines
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

[Adverse drug reactions of psychotropic agents : adverse drug reactions and safety monitoring of psychotropic agents]. / Miura, Tomofumi; Nakanishi, Shoichiro; Kanba, Shigenobu; Uchida, Hiroyuki; Saio, Takeo; Suzuki, Eiji; Suzuki, Yutaro; Takahashi, Keisuke; Nakagawa, Atsuo; Mikuni, Masahiko; Yamada, Kazuo.

In: Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, Vol. 116, No. 9, 01.01.2014, p. 735-745.

Research output: Contribution to journalReview article

Miura, T, Nakanishi, S, Kanba, S, Uchida, H, Saio, T, Suzuki, E, Suzuki, Y, Takahashi, K, Nakagawa, A, Mikuni, M & Yamada, K 2014, '[Adverse drug reactions of psychotropic agents: adverse drug reactions and safety monitoring of psychotropic agents]', Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, vol. 116, no. 9, pp. 735-745.
Miura, Tomofumi ; Nakanishi, Shoichiro ; Kanba, Shigenobu ; Uchida, Hiroyuki ; Saio, Takeo ; Suzuki, Eiji ; Suzuki, Yutaro ; Takahashi, Keisuke ; Nakagawa, Atsuo ; Mikuni, Masahiko ; Yamada, Kazuo. / [Adverse drug reactions of psychotropic agents : adverse drug reactions and safety monitoring of psychotropic agents]. In: Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica. 2014 ; Vol. 116, No. 9. pp. 735-745.
@article{998930d7dbc0454a974f41220a3fef1b,
title = "[Adverse drug reactions of psychotropic agents: adverse drug reactions and safety monitoring of psychotropic agents]",
abstract = "Pharmacological treatments of psychiatric illness have been developed and many psychotropic drugs are now on the market. The body of safety information regarding psychotropic agents is so large that it is difficult for clinicians to consider all the details of possible adverse drug reactions(ADRs) in daily clinical practice. Although it is impossible to predict and prevent all occurrences of ADRs, many of them may be preventable. In this context, there is a strong need for compact manuals of diagnosis and treatment for ADRs arising from psychotropic agents that are likely to be used in daily practice. Under the auspices of the Japanese Society of Psychiatry and Neurology, a task force was convened to answer this need. This review focuses on the general considerations of ADRs with psychotropic agents, based on discussions of the task force. We also discuss the guidelines for drug safety monitoring, targeted towards specific psychiatric disorders or patients taking specific classes of drugs. Finally, we introduce the Adverse Drug Reactions Relief System in Japan.",
author = "Tomofumi Miura and Shoichiro Nakanishi and Shigenobu Kanba and Hiroyuki Uchida and Takeo Saio and Eiji Suzuki and Yutaro Suzuki and Keisuke Takahashi and Atsuo Nakagawa and Masahiko Mikuni and Kazuo Yamada",
year = "2014",
month = "1",
day = "1",
language = "English",
volume = "116",
pages = "735--745",
journal = "Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica",
issn = "0033-2658",
publisher = "Japanese Society of Psychiatry and Neurology",
number = "9",

}

TY - JOUR

T1 - [Adverse drug reactions of psychotropic agents

T2 - adverse drug reactions and safety monitoring of psychotropic agents]

AU - Miura, Tomofumi

AU - Nakanishi, Shoichiro

AU - Kanba, Shigenobu

AU - Uchida, Hiroyuki

AU - Saio, Takeo

AU - Suzuki, Eiji

AU - Suzuki, Yutaro

AU - Takahashi, Keisuke

AU - Nakagawa, Atsuo

AU - Mikuni, Masahiko

AU - Yamada, Kazuo

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Pharmacological treatments of psychiatric illness have been developed and many psychotropic drugs are now on the market. The body of safety information regarding psychotropic agents is so large that it is difficult for clinicians to consider all the details of possible adverse drug reactions(ADRs) in daily clinical practice. Although it is impossible to predict and prevent all occurrences of ADRs, many of them may be preventable. In this context, there is a strong need for compact manuals of diagnosis and treatment for ADRs arising from psychotropic agents that are likely to be used in daily practice. Under the auspices of the Japanese Society of Psychiatry and Neurology, a task force was convened to answer this need. This review focuses on the general considerations of ADRs with psychotropic agents, based on discussions of the task force. We also discuss the guidelines for drug safety monitoring, targeted towards specific psychiatric disorders or patients taking specific classes of drugs. Finally, we introduce the Adverse Drug Reactions Relief System in Japan.

AB - Pharmacological treatments of psychiatric illness have been developed and many psychotropic drugs are now on the market. The body of safety information regarding psychotropic agents is so large that it is difficult for clinicians to consider all the details of possible adverse drug reactions(ADRs) in daily clinical practice. Although it is impossible to predict and prevent all occurrences of ADRs, many of them may be preventable. In this context, there is a strong need for compact manuals of diagnosis and treatment for ADRs arising from psychotropic agents that are likely to be used in daily practice. Under the auspices of the Japanese Society of Psychiatry and Neurology, a task force was convened to answer this need. This review focuses on the general considerations of ADRs with psychotropic agents, based on discussions of the task force. We also discuss the guidelines for drug safety monitoring, targeted towards specific psychiatric disorders or patients taking specific classes of drugs. Finally, we introduce the Adverse Drug Reactions Relief System in Japan.

UR - http://www.scopus.com/inward/record.url?scp=84925286618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925286618&partnerID=8YFLogxK

M3 - Review article

C2 - 25711116

AN - SCOPUS:84925286618

VL - 116

SP - 735

EP - 745

JO - Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica

JF - Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica

SN - 0033-2658

IS - 9

ER -